Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amyl nitrite is a small molecule vasodilator of the alkyl nitrite class, historically used for the rapid relief of angina pectoris and as an antidote for cyanide poisoning. It acts by relaxing vascular smooth muscle, leading to decreased systemic vascular resistance and reduced cardiac preload and afterload. The primary mechanism involves the release of nitric oxide, which induces smooth muscle relaxation via cyclic GMP signaling pathways. As an antidote to cyanide poisoning, it promotes the formation of methemoglobin that binds cyanide ions to form nontoxic cyanmethemoglobin. Amyl nitrite is administered by inhalation; its effects are felt within seconds and last several minutes. It has also been misused recreationally due to its psychoactive effects[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amyl nitrite.